Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to ...
Multiple modalities mean more options for students–and more options for students can translate to greater enrollment and diversity. We’re already seeing the proof of this concept. When most ...
Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global multiple modalities in oncology market is advancing rapidly, with revenues expected to reach hundreds of millions between 2025 and 2034. This ...
Thanks to rapid vaccine distribution and the CDC’s new mask guidance, in-person instruction returned en masse to universities across the country this fall. But that doesn’t mean university programs ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Please provide your email address to receive an email when new articles are posted on . Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while ...
Oral presentation shares head-to-head results for investigational combination pozelimab plus cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria Initial results for odronextamab in first ...
Optically guided surgical approach and the outcome of early-stage oral cancers. Background: We started a prospective cohort study in August 2003 to evaluate the utility of whole- body cancer screening ...
Artificial intelligence in its most successful form -- things like ChatGPT or DeepMind's AlphaFold to predict proteins -- has been trapped in one conspicuously narrow dimension: The AI sees things ...
(MENAFN- GlobeNewsWire - Nasdaq) The growth of the multiple modalities in oncology market is driven by the growing incidence of cancer and advances in precision medicine and diagnostics, reports ...
Additional oral presentations explore odronextamab in areas of high unmet need, including the primary analysis in diffuse large B-cell lymphoma progressing after CAR-T therapy and first results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results